Home > Boards > US Listed > Medical - Drugs > MyMD Pharmaceuticals Inc (MYMD)

Today's filing with the S.E.C. is a real

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
knuts4oe Member Profile
 
Followed By 3
Posts 594
Boards Moderated 0
Alias Born 06/26/13
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 9/13/2021 5:31:32 PM
MyMD Pharmaceuticals Announces Fourth Quarter 2021 Initiation of Phase 2 Clinical Trial of MYMD-1 for Extending Healthy Lifespan Business Wire - 9/13/2021 10:00:00 AM
MyMD Pharmaceuticals to Present its Novel Therapeutic Platforms for Extending Healthy Lifespan at the H.C. Wainwright 23rd Annual Global Investment Conference September 13-15 Business Wire - 9/9/2021 10:15:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/3/2021 4:38:53 PM
MyMD Pharmaceuticals Announces Issuance of U.S. Patent for Use of Lead Candidate MYMD-1 for Treating Fibrosis and Asthma Business Wire - 8/24/2021 10:17:00 AM
MyMD Pharmaceuticals Announces Issuance of U.S. Patent for Synthetic Cannabinoid Compounds for Treating Neuroinflammatory and Neurodegenerative Diseases Business Wire - 8/10/2021 2:30:00 PM
MyMD Pharmaceuticals Subsidiary Oravax Medical Preparing to Commence Clinical Trials for Oral COVID-19 Vaccine Business Wire - 8/10/2021 10:30:00 AM
MyMD Pharmaceuticals’ Lead Compound MYMD-1 Shown to Suppress a Major Cause of Death in COVID-19 in Human Cell Study Business Wire - 8/5/2021 10:30:00 AM
MyMD Pharmaceuticals’ Lead Compound MYMD-1 Shows Commonality in Comparative Study with FDA-Approved Anti-Inflammatory and Anti-Autoimmune Drugs Used for Arthritis, Colitis and Dermatitis Business Wire - 7/27/2021 9:15:00 AM
MyMD Pharmaceuticals Announces New Data from Comparative Study on Lead Compound MYMD-1 Business Wire - 7/7/2021 9:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/2/2021 5:00:55 PM
Amended Current Report Filing (8-k/a) Edgar (US Regulatory) - 7/2/2021 4:01:25 PM
MyMD Pharmaceuticals Set to Join Russell Microcap® Index Business Wire - 6/7/2021 10:02:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/18/2021 6:11:59 AM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) Edgar (US Regulatory) - 5/18/2021 6:07:21 AM
MyMD Pharmaceuticals Appoints David Rini, Professor at the Johns Hopkins School of Medicine, to Scientific Advisory Board Business Wire - 5/17/2021 9:00:00 AM
MyMD Pharmaceuticals Schedules Business Update Conference Call Business Wire - 5/12/2021 9:00:00 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 5/12/2021 6:05:34 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 5/11/2021 4:28:20 PM
Securities Registration Statement (simplified Form) (s-3/a) Edgar (US Regulatory) - 4/28/2021 5:26:41 PM
Johns Hopkins Medicine Researchers to Present Data on MyMD Pharmaceuticals’ Supera-CBD at the 3rd Annual Neuroimmunology Dr... Business Wire - 4/28/2021 10:13:00 AM
Statement of Beneficial Ownership (sc 13d) Edgar (US Regulatory) - 4/27/2021 6:02:14 AM
MyMD Pharmaceuticals Announces Issuance of Allowance from United States Patent & Trademark Office for Synthetic Cannabinoid C... Business Wire - 4/22/2021 9:20:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/22/2021 6:04:24 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/21/2021 5:55:31 PM
knuts4oe   Thursday, 05/13/21 11:29:40 AM
Re: None
Post # of 146 
Today's filing with the S.E.C. is a real barn burner that knocked my socks off! They pull no punches as they lay out where they are at and where they plan to go! This is probably the basis of the presentation they are giving on Monday after the market closes. Check next message for link due to technical issues.





Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences